TSS
AQST icon

Two Sigma Securities’s Aquestive Therapeutics AQST Stock Holding History

Two Sigma Securities’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,770
Closed -$77.9K – 1714
2026
Q1 		$77.9K Buy
+18,770
New +$76.2K 0.01% 1205
2023
Q3 		– Sell
-21,937
Closed -$36.2K – 2905
2023
Q2 		$36.2K Buy
+21,937
New +$39.7K ﹤0.01% 2438

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Two Sigma Securities's AQST Position: Q2 2026 in Review

Two Sigma Securities sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 18,770 shares — an estimated $77.9K sold.

Two Sigma Securities first reported a position in AQST in Q2 2023 and held it in 2 quarters. The position peaked at $77.9K in Q1 2026. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Two Sigma Securities reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 18,770 Aquestive Therapeutics shares in Q2 2026, an estimated $77.9K.
  • Two Sigma Securities first reported a position in Aquestive Therapeutics in Q2 2023 and held it in 2 quarters.
  • Two Sigma Securities's Aquestive Therapeutics position peaked at $77.9K in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.